IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.932
AS - Asia 7.372
EU - Europa 6.784
SA - Sud America 1.433
AF - Africa 138
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 15
Totale 29.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.734
CN - Cina 2.751
SG - Singapore 2.335
UA - Ucraina 1.797
BR - Brasile 1.236
PL - Polonia 957
IT - Italia 892
DE - Germania 844
HK - Hong Kong 808
FI - Finlandia 508
GB - Regno Unito 453
VN - Vietnam 434
FR - Francia 426
IN - India 333
TR - Turchia 307
IE - Irlanda 293
RU - Federazione Russa 287
CA - Canada 109
BD - Bangladesh 87
SE - Svezia 74
AR - Argentina 67
CZ - Repubblica Ceca 54
MX - Messico 54
BE - Belgio 51
IQ - Iraq 50
ZA - Sudafrica 48
ID - Indonesia 42
EC - Ecuador 38
IR - Iran 36
ES - Italia 27
JP - Giappone 27
KR - Corea 27
AT - Austria 23
NL - Olanda 22
PK - Pakistan 21
AU - Australia 20
CH - Svizzera 19
KE - Kenya 19
VE - Venezuela 19
EG - Egitto 17
MA - Marocco 16
UZ - Uzbekistan 16
EU - Europa 15
PY - Paraguay 15
CL - Cile 14
CO - Colombia 14
MU - Mauritius 14
SA - Arabia Saudita 14
UY - Uruguay 11
IL - Israele 10
JO - Giordania 10
PE - Perù 10
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
BO - Bolivia 7
KG - Kirghizistan 7
BA - Bosnia-Erzegovina 6
ET - Etiopia 6
PA - Panama 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
GR - Grecia 5
NP - Nepal 5
PS - Palestinian Territory 5
RO - Romania 5
AL - Albania 4
AM - Armenia 4
JM - Giamaica 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
PT - Portogallo 3
BB - Barbados 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TJ - Tagikistan 2
TO - Tonga 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 29.679
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Jacksonville 1.290
Singapore 1.121
Ashburn 1.012
Warsaw 952
Houston 915
Hong Kong 805
Ann Arbor 790
Cambridge 681
Seattle 584
Chandler 579
Wilmington 572
Princeton 527
Beijing 517
Nanjing 466
Brescia 329
New York 308
Dublin 291
Dearborn 279
Istanbul 238
Los Angeles 229
Helsinki 221
The Dalles 184
Nanchang 182
Shenyang 148
Ho Chi Minh City 146
Munich 141
Des Moines 131
Hebei 131
Moscow 116
Buffalo 110
Tianjin 105
Milan 100
Jinan 98
Changsha 92
São Paulo 90
Hanoi 88
Shanghai 88
San Diego 77
Pune 73
San Francisco 70
Jiaxing 69
Dallas 65
Lancaster 65
Redondo Beach 61
Toronto 60
London 53
Kunming 51
Chicago 49
San Mateo 48
Turku 47
Brussels 45
Hangzhou 45
Santa Clara 45
Dong Ket 42
Verona 42
Ningbo 40
Brno 38
Rio de Janeiro 38
Kocaeli 36
Augusta 35
Guangzhou 35
Denver 33
Ardabil 32
Leawood 32
Zhengzhou 32
San Donà Di Piave 31
Brooklyn 29
Brasília 28
Haikou 28
Orem 28
Monmouth Junction 27
Poplar 27
Taizhou 27
Johannesburg 26
Boardman 25
Tokyo 25
Montreal 24
Norwalk 24
Romola 23
Lanzhou 21
Phoenix 21
Belo Horizonte 20
Mexico City 19
Atlanta 17
Frankfurt am Main 17
Jakarta 17
Nairobi 17
Rome 17
Ankara 16
Da Nang 16
Changchun 15
Dhaka 15
Haiphong 15
Mumbai 15
Orange 15
Taiyuan 15
Baghdad 14
Basel 14
Totale 19.757
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 295
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 289
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 282
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 249
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 247
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 234
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 228
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 223
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 212
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 207
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 206
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 193
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 191
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 186
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 180
The D3 dopamine receptor: From structural interactions to function. 171
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 171
Palbociclib inhibits proliferation of human adrenocortical tumor cells 171
Age-related changes of enkephalin in rat spinal cord 166
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 166
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 166
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 163
A new pharmacological approach to the facilitation of acetylcholine transmission. 160
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 160
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 158
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 158
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 157
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 153
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 152
A superfusion method for the study of calcium fluxes from pituitary cells. 152
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 152
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 151
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 150
Synapsin III alterations in Parkinson's disease 149
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 148
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 148
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 147
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 146
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 145
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 145
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 145
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 144
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 140
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 140
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 138
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 137
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 137
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 136
Ormoni Anteroipofisari 136
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 136
Pharmacological basis for dopamine D-2 receptor diversity 135
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 135
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 134
Caveolins in rhabdomyosarcoma 133
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 133
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 132
Dopamine receptors are present in rat and human esophagus 132
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 131
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 130
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 128
Nerve growth factor signaling in prostate health and disease. 128
Sex-related variations in serum nerve growth factor concentration in humans. 127
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 127
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 127
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 126
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 126
Synapsin III Alteration in Parkinson's disease 126
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 126
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 125
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 125
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 125
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 124
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 124
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 124
Different neurotransmitter systems are involved in the development of esophageal achalasia 123
The NMDA/D1 receptor complex as a new target in drug development 123
Vasoactive Intestinal Polypeptide (VIP) selectively stimulates prolactin release in healthy women 123
Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens 123
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 123
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 122
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 122
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 122
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 121
Synapsin III Alteration in Parkinson's disease 121
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 121
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 121
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 121
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 120
Nerve growth factor in pituitary development and pituitary tumors 120
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 120
Presenilin-2 mutations alter cystatin C trafficking in mouse primary neurons. 119
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 119
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 119
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 119
[Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. 119
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 119
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine 119
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter 118
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 118
Afferent fibers mediate the increse of met-enkephalin elicited in rat spinal cord by localized pain. 118
Totale 14.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.577 0 0 0 0 0 411 193 465 565 287 536 120
2021/20222.156 195 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20254.242 23 46 58 545 471 346 407 105 511 286 877 567
2025/20265.028 753 1.112 658 1.335 755 415 0 0 0 0 0 0
Totale 30.519